ORLANDO Pain medicine investigators will present preliminary research findings on Thursday, February 14, 2008, at poster sessions held during the 24th annual meeting of the American Academy of Pain Medicine at the Gaylord Palms, Orlando, February 12-16, 2008.
All abstract titles are listed in this document. The introduction, conclusion, investigator listing, and funding source are included for eight abstracts identified as being of interest to the media.
Smoking and Neuropathic Pain
Introduction: This study aims to determine the percentage of community subjects with chronic neuropathic pain that smoke. (205 subjects)
Conclusions: Smoking was twice as common (62% versus 33%) in subjects that were diagnosed by clinical assessment as having neuropathic versus nociceptive pain. Similar differences were not found among those positive and negative on screening assessment for neuropathic pain. The possible physiological relationship between smoking and development of chronic neuropathic pain deserves further evaluation.
Investigators: Todd G. Call, MD Mayo, Toby N. Weingarten, MD, James C. Watson, MD, W. Michael Hooten, MD, Peter C. Wollan, PhD Mayo, Lee J. Melton, MD, Barbara P. Yawn, MD, Mayo Clinic College of Medicine, Rochester, MN
Editors note: Funding was provided by AstraZeneca and NIH grant AR30852.
What Are the Variables That Are Associated with the Patients Wish to Sue His Physician in Patients with Acute and Chronic Pain?
Objectives: Although there is limited research on patient attributes that may be related to reasons for launching a malpractice suit, no such research has been performed in patients with acute (APPS) or chronic (CPPS) pain. The objective of this study was then to develop some statistical models that would describe such patients attributes.
Conclusions: CPPS are at greater risk than patients without pain and APPS for harboring
|Contact: Amy Jenkins|
American Academy of Pain Medicine